Clinical trials
Observational Down Syndrome trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
3 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2015 | 1 |
| 2017 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BioCeryx | 1 |
| Natera, Inc. | 1 |
| Women and Infants Hospital of Rhode Island | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Down Syndrome | 3 |
| Aneuploidy | 2 |
| 22q11 Deletion Syndrome | 1 |
| Angelman Syndrome | 1 |
| Cri-du-Chat Syndrome | 1 |
| DiGeorge Syndrome | 1 |
| Prader-Willi Syndrome | 1 |
| Sex Chromosome Aberrations | 1 |
| Trisomy | 1 |
| Trisomy 13 Syndrome | 1 |
Trials
Showing 1 to 3 of 3. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.